Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Showa Inan General Hospital | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To examine the safety and effectiveness after Xeljanz treatment in rheumatoid arthritis patients
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| The condition of rheumatoid arthritis | Experimental |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| The effectiveness of Xeljanz in rheumatoid arthritis patients | Drug |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change from baseline of clinical evaluation in rheumatoid arthritis | DAS28, SDAI, Blood testing, Plain radiograph, and Ultrasound will be performed. | Every month |
| Measure | Description | Time Frame |
|---|---|---|
| Number of participants with adverse events | Every month |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Yukio Nakamura, MD, PhD | Contact | yxn14@aol.jp |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Yukio Nakamura | Recruiting | Matsumoto | Nagano | 3908621 | Japan |
Not provided
| ID | Term |
|---|---|
| D001172 | Arthritis, Rheumatoid |
| ID | Term |
|---|---|
| D001168 | Arthritis |
| D007592 | Joint Diseases |
| D009140 | Musculoskeletal Diseases |
| D012216 | Rheumatic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| D003240 |
| Connective Tissue Diseases |
| D017437 | Skin and Connective Tissue Diseases |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |